NCT00004846View on ClinicalTrials.gov

Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV

CompletedOBSERVATIONAL
Enrollment

30,000

Participants

Timeline

Start Date

December 31, 1999

Study Completion Date

October 31, 2002

Conditions
Hepatitis CHIV Infection
Interventions
DRUG

ABC/Gen-Probe/Chiron HIV-1/HCV 001

Trial Locations (1)

20892

Warren G. Magnuson Clinical Center (CC), Bethesda

All Listed Sponsors
lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00004846 - Nucleic Acid Amplification Testing (NAT) of Blood Donors for HCV and HIV | Biotech Hunter | Biotech Hunter